MicroRNAs 17-5p–20a–106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation
暂无分享,去创建一个
Carlo M. Croce | Elvira Pelosi | Cesare Peschle | C. Croce | C. Peschle | E. Brunetti | U. Testa | E. Pelosi | F. Grignani | L. Fontana | F. Liuzzi | Ugo Testa | Laura Fontana | Paolo Greco | Serena Racanicchi | Francesca Liuzzi | Ercole Brunetti | Francesco Grignani | Serena Racanicchi | Paolo Greco | S. Racanicchi
[1] F. Tirone,et al. Btg2 Enhances Retinoic Acid-Induced Differentiation by Modulating Histone H4 Methylation and Acetylation , 2006, Molecular and Cellular Biology.
[2] W. Filipowicz,et al. Relief of microRNA-Mediated Translational Repression in Human Cells Subjected to Stress , 2006, Cell.
[3] C. Peschle,et al. Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells. , 2006, Blood.
[4] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[5] G. Hannon,et al. Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.
[6] Annick Harel-Bellan,et al. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation , 2006, Nature Cell Biology.
[7] Jian-Fu Chen,et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.
[8] C. Croce,et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[9] Alessandro Fatica,et al. A Minicircuitry Comprised of MicroRNA-223 and Transcription Factors NFI-A and C/EBPα Regulates Human Granulopoiesis , 2005, Cell.
[10] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[11] C. Buske,et al. AML1-ETO Needs a Partner: New Insights into the Pathogenesis of t(8;21) Leukemia , 2005, Cell cycle.
[12] Y. Yatabe,et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. , 2005, Cancer research.
[13] Yong Zhao,et al. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.
[14] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[15] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[16] H. Taubert,et al. Gains of 13q are correlated with a poor prognosis in liposarcoma , 2005, Modern Pathology.
[17] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[18] J. Kutok,et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. , 2004, Blood.
[19] Sanghyuk Lee,et al. MicroRNA genes are transcribed by RNA polymerase II , 2004, The EMBO journal.
[20] Anton J. Enright,et al. Human MicroRNA Targets , 2004, PLoS biology.
[21] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[22] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.
[23] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.
[24] C. Croce,et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[25] Peter F Stadler,et al. Molecular evolution of a microRNA cluster. , 2004, Journal of molecular biology.
[26] D. Littman,et al. Epigenetic gene silencing by Runx proteins , 2004, Oncogene.
[27] Hiroyuki Tagawa,et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. , 2004, Cancer research.
[28] Thomas Tuschl,et al. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. , 2004, RNA.
[29] Phillip D Zamore,et al. Sequence-Specific Inhibition of Small RNA Function , 2004, PLoS biology.
[30] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[31] D. Bartel,et al. MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.
[32] Nóra Varga,et al. Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes. , 2004, Nucleic acids research.
[33] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[34] G. Morgan,et al. Epigenetic consequences of AML1–ETO action at the human c‐FMS locus , 2003, The EMBO journal.
[35] C. Peschle,et al. Identification of the hemangioblast in postnatal life. , 2002 .
[36] D. Gilliland,et al. Core-binding factors in haematopoiesis and leukaemia , 2002, Nature Reviews Cancer.
[37] K. MacKenzie,et al. The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. , 2002, Blood.
[38] D. Tenen,et al. Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. , 2000, Blood.
[39] K. Pritchard-Jones,et al. A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma , 2000, Genes, chromosomes & cancer.
[40] S. Srinivasula,et al. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 , 1999, Nature.
[41] G. Condorelli,et al. Unilineage hematopoietic differentiation in bulk and single cell culture , 1998, Stem cells.
[42] J. Zhang,et al. AML1A and AML1B can transactivate the human IL-3 promoter. , 1997, Journal of immunology.
[43] C. Peschle,et al. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. , 1996, Blood.
[44] M. Marín‐Padilla,et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[45] T. Golub,et al. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription , 1996, Molecular and cellular biology.
[46] D. Tenen,et al. CCAAT Enhancer-Binding Protein ( C / EBP ) and AML 1 ( CBF a 2 ) Synergistically Activate the Macrophage Colony-Stimulating Factor Receptor Promoter , 1995 .
[47] J. Downing,et al. AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.
[48] J. Zhang,et al. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. , 1995, Oncogene.
[49] S Meyers,et al. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells , 1994, Molecular and cellular biology.
[50] Myriam Alcalay,et al. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells , 1993, Cell.
[51] Stanley Er. Action of the colony-stimulating factor, CSF-1. , 1986 .
[52] E. Stanley,et al. Action of the colony-stimulating factor, CSF-1. , 1986, Ciba Foundation symposium.